StockData
Neogen Corp logo

Neogen Corp (NEOG) stock

NEOGNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 7, 2026Score 7/3049% above fair value
$10.90+0.02 (+0.18%)

Close on Nov 17, 2026Market cap $2.38BP/E –Yield –

Neogen gross margin

Gross margin is gross profit as a percentage of revenue.

Neogen's gross margin for the twelve months ending Aug 31, 2026 was 47.4%. For fiscal 2026 it was 46.9%, against 47.1% the year before. The highest annual figure on record is 52.8% in fiscal 2013.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2026May 31, 202646.9%−0.2
FY2025May 31, 202547.1%−3.1
FY2024May 31, 202450.2%+0.8
FY2023May 31, 202349.4%+3.3
FY2022May 31, 202246.1%+0.2
FY2021May 31, 202145.9%−1.0
FY2020May 31, 202046.9%+0.6
FY2019May 31, 201946.3%−0.5
FY2018May 31, 201846.8%−0.3
FY2017May 31, 201747.1%−0.5
FY2016May 31, 201647.6%−1.7
FY2015May 31, 201549.3%−0.2
FY2014May 31, 201449.6%−3.2
FY2013May 31, 201352.8%+2.5
FY2012May 31, 201250.2%−0.6
FY2011May 31, 201150.8%−1.1
FY2010May 31, 201051.9%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2027CQ3 2026Aug 31, 202647.4%+1.9
Q4 FY2026CQ2 2026May 31, 202647.8%+6.6
Q3 FY2026CQ1 2026Feb 28, 202646.9%−3.0
Q2 FY2026CQ4 2025Nov 30, 202547.5%−1.5
Q1 FY2026CQ3 2025Aug 31, 202545.4%−2.9
Q4 FY2025CQ2 2025May 31, 202541.2%−6.7
Q3 FY2025CQ1 2025Feb 28, 202549.9%−1.2
Q2 FY2025CQ4 2024Nov 30, 202449.0%−1.8
Q1 FY2025CQ3 2024Aug 31, 202448.4%−2.6
Q4 FY2024CQ2 2024May 31, 202447.9%−3.0
Q3 FY2024CQ1 2024Feb 29, 202451.1%+1.6
Q2 FY2024CQ4 2023Nov 30, 202350.9%+1.9
Q1 FY2024CQ3 2023Aug 31, 202351.0%+3.9
Q4 FY2023CQ2 2023May 31, 202350.9%+4.5
Q3 FY2023CQ1 2023Feb 28, 202349.5%+4.7
Q2 FY2023CQ4 2022Nov 30, 202248.9%+2.5
Q1 FY2023CQ3 2022Aug 31, 202247.0%+0.3
Q4 FY2022CQ2 2022May 31, 202246.4%+1.1
Q3 FY2022CQ1 2022Feb 28, 202244.8%−1.4
Q2 FY2022CQ4 2021Nov 30, 202146.4%+0.2
Q1 FY2022CQ3 2021Aug 31, 202146.8%+0.8
Q4 FY2021CQ2 2021May 31, 202145.3%−2.2
Q3 FY2021CQ1 2021Feb 28, 202146.1%+0.8
Q2 FY2021CQ4 2020Nov 30, 202046.3%−1.1
Q1 FY2021CQ3 2020Aug 31, 202046.0%−1.5
Q4 FY2020CQ2 2020May 31, 202047.4%+1.4
Q3 FY2020CQ1 2020Feb 29, 202045.4%−0.3
Q2 FY2020CQ4 2019Nov 30, 201947.3%+0.6
Q1 FY2020CQ3 2019Aug 31, 201947.5%+0.6
Q4 FY2019CQ2 2019May 31, 201946.0%+1.2
Q3 FY2019CQ1 2019Feb 28, 201945.7%−1.3
Q2 FY2019CQ4 2018Nov 30, 201846.7%−1.2
Q1 FY2019CQ3 2018Aug 31, 201846.9%−0.8
Q4 FY2018CQ2 2018May 31, 201844.9%−2.7
Q3 FY2018CQ1 2018Feb 28, 201847.0%+0.7
Q2 FY2018CQ4 2017Nov 30, 201747.9%−0.1
Q1 FY2018CQ3 2017Aug 31, 201747.7%–
Q4 FY2017CQ2 2017May 31, 201747.6%–
Q3 FY2017CQ1 2017Feb 28, 201746.3%–
Q2 FY2017CQ4 2016Nov 30, 201648.1%–

More Neogen figures

See a number that looks wrong?